{
    "organizations": [],
    "uuid": "e58784b6652710daa65d092d0503f4707fb917c0",
    "author": "cnbc.com",
    "url": "http://www.cnbc.com/2018/02/12/business-wire-clovis-oncology-to-announce-fourth-quarter-and-full-year-2017-financial-results-and-host-webcast-conference-call-on-february.html",
    "ord_in_thread": 0,
    "title": "Clovis Oncology to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 26",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "BOULDER, Colo.--(BUSINESS WIRE)-- Clovis Oncology, Inc. (NASDAQ: CLVS) will announce its fourth quarter and full year 2017 financial results on Monday, February 26, 2018, after the close of the U.S. financial markets. Clovis’ senior management will host a conference call and live audio webcast at 4:30 p.m. ET to discuss the company’s results in greater detail.\nThe conference call is being webcast and can be accessed from the Clovis Oncology website at www.clovisoncology.com . A replay of the webcast will be available for 30 days.\nConference Call Details\nClovis will hold a conference call to discuss fourth quarter and full year 2017 results on February 26 at 4:30 p.m. ET. The conference call will be simultaneously webcast on the Company’s web site at www.clovisoncology.com , and archived for future review. Dial-in numbers for the conference call are as follows: US participants 866.489.9022, International participants 678.509.7575, conference ID: 3097118 .\nAbout Clovis Oncology\nClovis Oncology, Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the U.S., Europe and additional international markets. Clovis Oncology targets development programs at specific subsets of cancer populations, and simultaneously develops, with partners, diagnostic tools that direct a compound in development to the population that is most likely to benefit from its use. Clovis Oncology is headquartered in Boulder, Colorado, and has additional offices in San Francisco, California and Cambridge, UK.\nView source version on businesswire.com : http://www.businesswire.com/news/home/20180212005035/en/\nClovis Oncology, Inc.\nBreanna Burkart, 303-625-5023\nbburkart@clovisoncology.com\nor\nAnna Sussman, 303-625-5022\nasussman@clovisoncology.com\nSource: Clovis Oncology, Inc.",
    "published": "2018-02-13T00:05:00.000+02:00",
    "crawled": "2018-02-13T01:58:17.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "boulder",
        "business",
        "wire",
        "clovis",
        "oncology",
        "nasdaq",
        "clvs",
        "announce",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "monday",
        "february",
        "close",
        "financial",
        "market",
        "clovis",
        "senior",
        "management",
        "host",
        "conference",
        "call",
        "live",
        "audio",
        "webcast",
        "et",
        "discus",
        "company",
        "result",
        "greater",
        "detail",
        "conference",
        "call",
        "webcast",
        "accessed",
        "clovis",
        "oncology",
        "website",
        "replay",
        "webcast",
        "available",
        "day",
        "conference",
        "call",
        "detail",
        "clovis",
        "hold",
        "conference",
        "call",
        "discus",
        "fourth",
        "quarter",
        "full",
        "year",
        "result",
        "february",
        "et",
        "conference",
        "call",
        "simultaneously",
        "webcast",
        "company",
        "web",
        "site",
        "archived",
        "future",
        "review",
        "number",
        "conference",
        "call",
        "follows",
        "u",
        "participant",
        "international",
        "participant",
        "conference",
        "id",
        "clovis",
        "oncology",
        "clovis",
        "oncology",
        "biopharmaceutical",
        "company",
        "focused",
        "acquiring",
        "developing",
        "commercializing",
        "innovative",
        "agent",
        "europe",
        "additional",
        "international",
        "market",
        "clovis",
        "oncology",
        "target",
        "development",
        "program",
        "specific",
        "subset",
        "cancer",
        "population",
        "simultaneously",
        "develops",
        "partner",
        "diagnostic",
        "tool",
        "direct",
        "compound",
        "development",
        "population",
        "likely",
        "benefit",
        "use",
        "clovis",
        "oncology",
        "headquartered",
        "boulder",
        "colorado",
        "additional",
        "office",
        "san",
        "francisco",
        "california",
        "cambridge",
        "uk",
        "view",
        "source",
        "version",
        "http",
        "clovis",
        "oncology",
        "breanna",
        "burkart",
        "bburkart",
        "anna",
        "sussman",
        "asussman",
        "source",
        "clovis",
        "oncology",
        "inc"
    ]
}